Cml Healthcare Inc news

   Watch this stock
Showing stories 1 - 10 of about 62   

Articles published

CLC 0.0000
price chart
DIPP seeks details on blood cancer drug Dasatinib for issuance of compulsory ...
"The DIPP has sent a set of nine questions to the Health Ministry seeking details on Dasatinib and prevalence of CML in India, and whether the situation could be termed national emergency or extreme urgency as its occurrence is very rare just 0.001 per ...
Related articles »  
Port Maria Hospital, Central Medical Lab forge partnership
CML's customer service manager for the north coast, Caroline Lee, claims the company, now run by Clarke's daughter, Audrey, has built a solid reputation for delivering quality health-care services by partnering wherever possible with PMH and focusing ...
ARIAD's Iclusig Gains Positive Recommendation from PRAC - Analyst Blog
Late last week, ARIAD Pharmaceuticals Inc. ( ARIA ) announced that PRAC provided a positive risk/benefit assessment following the completion of review of Iclusig under the Article 20 referral procedure.
Europe's Rx Risk Assessment Group Recommends Keeping Iclusig Indications ...  GenomeWeb
Related articles »  
Essential: voters happy with government's Ebola response
Without healthcare workers on the ground, it is only a matter of time before this disease spreads around the world. Think about the ... Yes CML (#1) epidemics and pandemics, like interest rates, should be the preserve of experts, not politicians ...
Related articles »  
EMA safety panel rules no change needed for Ariad's Iclusig
Iclusig was approved in the US and EU last year for the treatment of adult patients with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), but quickly ran into problems after it was linked to an ...
Related articles »  
County prepares to handle emergencies; will wait a year for government ...
Community volunteers and students from CML Snider Public School participated in the drill, acting as displaced residents, and placing phone calls as concerned residents.
EMA Panel Says Not Enough Evidence for Lower Dosing of ARIAD Pharma's ...
However, updates to the product information are recommended to provide healthcare professionals with the latest evidence, in case they wish to consider reducing the dose in patients with 'chronic phase' CML who are responding well to treatment, and who ...
ARIAD Announces Recommendation for Iclusig by the Pharmacovigilance Risk ...  MarketWatch
Related articles »  
Beecher: we must ask tough questions about the ABC
Should the ABC kill Lateline? Why is there no longer a place on ABC TV for a movie reviewing program? Does the ABC have an added responsibility to produce more quality journalism at a time when commercial media is retrenching thousands of journalists ...
Related articles »  
From a mutation: Peshawar reports highest number of chronic myeloid ...
PESHAWAR: As many as 860 patients in Khyber-Pakhtunkhwa (K-P) are suffering from chronic myeloid leukaemia (CML), a form of blood cancer, while every month 15 to 20 people are diagnosed with the disease.
The revolution will be personalized: An interview with two Stanford geneticists
Starr offers a bold take on the not-so-distant future of U.S. healthcare: "Certainly, within a decade, I think everyone will have their complete DNA sequenced.